Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
Clinical trial NCT04470778 · COMPLETED
Trial details
- NCT number
- NCT04470778
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2021-03-21
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.